1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Dietary oats and modulation of atherogenic pathways.
(
- Contribution to journal › Scientific review
-
Mark
Effects of Pediococcus parvulus 2.6 and its exopolysaccharide on plasma cholesterol levels and inflammatory markers in mice
(
- Contribution to journal › Article
-
Mark
Evaluation of commercial microbial hydrocolloids concerning their effects on plasma lipids and caecal formation of SCFA in mice
(
- Contribution to journal › Article
-
Mark
Late onset vascular dysfunction in the R6/1 model of Huntington's disease.
2012) In European Journal of Pharmacology(
- Contribution to journal › Article
- 2011
-
Mark
Simultaneous intake of oat bran and atorvastatin reduces their efficacy to lower lipid levels and atherosclerosis in LDLr-/- mice
(
- Contribution to journal › Article
- 2010
-
Mark
Oats (Avena sativa) reduce atherogenesis in LDL-receptor-deficient mice.
(
- Contribution to journal › Article
-
Mark
Down-regulation of endothelial cell estrogen receptor expression by the inflammation promoter LPS.
(
- Contribution to journal › Article
-
Mark
Effects of oats on plasma cholesterol and lipoproteins in C57BL/6 mice are substrain specific.
(
- Contribution to journal › Article
-
Mark
Effects of oat bran, processed to different molecular weights of beta-glucan, on plasma lipids and caecal formation of SCFA in mice.
(
- Contribution to journal › Article
- 2009
-
Mark
Cholesterol-lowering and anti-atherogenic effects of oats in mice
(
- Thesis › Doctoral thesis (compilation)